My Treatment Approach to Gout

Fawad Aslam, Clement Michet

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Gout is the most common form of inflammatory arthritis in the United States. Nevertheless, gout remains misunderstood, misdiagnosed, underdiagnosed, and undertreated. Several new recommendation and guideline documents regarding the management of gout have been published in the past few years. New diagnostic modalities, such as ultrasound and dual-energy computed tomography, are now available. Newer treatment options exist, and older agents and their interactions are now better understood. This review addresses these recent diagnostic and therapeutic developments and describes our management protocol with the aim of providing the clinician with a pragmatic approach to gout management.

Original languageEnglish (US)
Pages (from-to)1234-1247
Number of pages14
JournalMayo Clinic proceedings
Volume92
Issue number8
DOIs
StatePublished - Aug 1 2017

Fingerprint

Gout
Diagnostic Errors
Arthritis
Tomography
Guidelines
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

My Treatment Approach to Gout. / Aslam, Fawad; Michet, Clement.

In: Mayo Clinic proceedings, Vol. 92, No. 8, 01.08.2017, p. 1234-1247.

Research output: Contribution to journalArticle

Aslam, Fawad ; Michet, Clement. / My Treatment Approach to Gout. In: Mayo Clinic proceedings. 2017 ; Vol. 92, No. 8. pp. 1234-1247.
@article{d26f4c76e6db4941a5b0074fcc2a90ce,
title = "My Treatment Approach to Gout",
abstract = "Gout is the most common form of inflammatory arthritis in the United States. Nevertheless, gout remains misunderstood, misdiagnosed, underdiagnosed, and undertreated. Several new recommendation and guideline documents regarding the management of gout have been published in the past few years. New diagnostic modalities, such as ultrasound and dual-energy computed tomography, are now available. Newer treatment options exist, and older agents and their interactions are now better understood. This review addresses these recent diagnostic and therapeutic developments and describes our management protocol with the aim of providing the clinician with a pragmatic approach to gout management.",
author = "Fawad Aslam and Clement Michet",
year = "2017",
month = "8",
day = "1",
doi = "10.1016/j.mayocp.2017.05.026",
language = "English (US)",
volume = "92",
pages = "1234--1247",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "8",

}

TY - JOUR

T1 - My Treatment Approach to Gout

AU - Aslam, Fawad

AU - Michet, Clement

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Gout is the most common form of inflammatory arthritis in the United States. Nevertheless, gout remains misunderstood, misdiagnosed, underdiagnosed, and undertreated. Several new recommendation and guideline documents regarding the management of gout have been published in the past few years. New diagnostic modalities, such as ultrasound and dual-energy computed tomography, are now available. Newer treatment options exist, and older agents and their interactions are now better understood. This review addresses these recent diagnostic and therapeutic developments and describes our management protocol with the aim of providing the clinician with a pragmatic approach to gout management.

AB - Gout is the most common form of inflammatory arthritis in the United States. Nevertheless, gout remains misunderstood, misdiagnosed, underdiagnosed, and undertreated. Several new recommendation and guideline documents regarding the management of gout have been published in the past few years. New diagnostic modalities, such as ultrasound and dual-energy computed tomography, are now available. Newer treatment options exist, and older agents and their interactions are now better understood. This review addresses these recent diagnostic and therapeutic developments and describes our management protocol with the aim of providing the clinician with a pragmatic approach to gout management.

UR - http://www.scopus.com/inward/record.url?scp=85028012261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028012261&partnerID=8YFLogxK

U2 - 10.1016/j.mayocp.2017.05.026

DO - 10.1016/j.mayocp.2017.05.026

M3 - Article

C2 - 28778257

AN - SCOPUS:85028012261

VL - 92

SP - 1234

EP - 1247

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 8

ER -